Clinical Trial Update: Activator vs the EF Class II Standard in the Treatment of Severe Overjet in Angle Class II Division 1 Malocclusion [NA]

View source ↗

Summary

A completed clinical trial comparing Activator versus EF Class II Standard for treating severe overjet in Class II Division 1 malocclusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Class Ii Division Malocclusion

Drugs mentioned

• Activator
• EF Class II Standard

Snippet

Sponsor: Can Tho University of Medicine and Pharmacy | Conditions: Class II Division 1 Malocclusion | NA | Status: COMPLETED